Old Web
English
Sign In
Acemap
>
authorDetail
>
Sarah M. Valencia
Sarah M. Valencia
Louisiana State University
Virology
Immune system
Biology
Antigen
Immunogenicity
4
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP.
2021
Human Vaccines & Immunotherapeutics
Sarah M. Valencia
Athina Zacharia
Alexander Marin
Rebecca L. Matthews
Chia-Kuei Wu
Breana Myers
Chelsea L. Sanders
Simone Difilippantonio
Reinhard Kirnbauer
Richard B.S. Roden
Ligia A. Pinto
Robert H. Shoemaker
Alexander K. Andrianov
Jason D. Marshall
Show All
Source
Cite
Save
Citations (0)
Next generation Polyphosphazene Immunoadjuvant: Synthesis, self-assembly and In Vivo potency with human papillomavirus VLPs-based vaccine
2021
Nanomedicine: Nanotechnology, Biology and Medicine
Alexander Marin
Ananda Chowdhury
Sarah M. Valencia
Athina Zacharia
Reinhard Kirnbauer
Richard B.S. Roden
A. Ligia
Robert H. Shoemaker
Jason D. Marshall
Alexander K. Andrianov
Show All
Source
Cite
Save
Citations (0)
Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists
2020
Vaccine
Athina Zacharia
Erin Harberts
Sarah M. Valencia
Breana Myers
Chelsea E Sanders
Akshay Jain
Nicholas R. Larson
C. Russell Middaugh
William D. Picking
Simone Difilippantonio
Reinhard Kirnbauer
Richard B.S. Roden
Ligia A. Pinto
Robert H. Shoemaker
Robert K. Ernst
Jason D. Marshall
Show All
Source
Cite
Save
Citations (2)
The BDLF3 gene product of Epstein-Barr virus, gp150, mediates non-productive binding to heparan sulfate on epithelial cells and only the binding domain of CD21 is required for infection.
2016
Virology
Liudmila S. Chesnokova
Sarah M. Valencia
Lindsey M. Hutt-Fletcher
Show All
Source
Cite
Save
Citations (9)
1